Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature.

Systemic lupus erythematosus (SLE) co-morbid with rheumatoid arthritis (RA) is known as 'Rhupus syndrome' and is estimated to be present in between 0.01 and 2% of SLE and RA patients. The occurrence of aplastic anaemia in a patient with rhupus is very rare and a treatment for this condition has not been reported. A 52-year-old woman presented complaining of nausea and dizziness during the preceding month. She had been treated for rheumatoid arthritis for 16 years. At the time of presentation, she had a malar rash, multiple arthritis, pancytopenia, pleural effusion, proteinuria, and positive anti-nuclear and anti-dsDNA antibodies. A kidney biopsy revealed ISN/RPS class IV-G (A) lupus nephritis. Bone marrow aspiration and biopsy showed aplastic anaemia with no evidence of viral infection. The patient was successfully treated using cyclosporine and prednisolone and she remained symptom-free at the one-and-a-half-year follow-up. To our knowledge, this is the first report of a successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anaemia.

[1]  L. Amezcua-Guerra.  Overlap Between Systemic Lupus Erythematosus and Rheumatoid Arthritis: Is It Real or Just an Illusion? , 2009, The Journal of Rheumatology.

[2]  T. Therneau,et al.  Systemic Lupus Erythematosus Features in Rheumatoid Arthritis and Their Effect on Overall Mortality , 2008, The Journal of Rheumatology.

[3]  R. Dhawan.  Associations of Erosive Arthritis with Anti-Cyclic Citrullinated Peptide Antibodies and MHC Class II Alleles in Systemic Lupus Erythematosus , 2009 .

[4]  D. Isenberg,et al.  Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality , 2007, Annals of the Rheumatic Diseases.

[5]  R. Márquez-Velasco,et al.  Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study , 2006, Arthritis research & therapy.

[6]  M. Alarcón-Riquelme.  The genetics of shared autoimmunity , 2005, Autoimmunity.

[7]  Marta E Alarcón-Riquelme,et al.  Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. , 2005, Arthritis and rheumatism.

[8]  Annette Lee,et al.  Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .

[9]  A. Prakash,et al.  Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine , 2004, Rheumatology International.

[10]  J. Granados,et al.  Clinical and immunogenetic characterization of Mexican patients with ‘Rhupus’ , 2002, Lupus.

[11]  M. Rowley,et al.  Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. , 1992, Annals of the rheumatic diseases.

[12]  P. Höcker,et al.  Oral cyclosporin‐A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure * , 1989, European journal of haematology.

[13]  L. Bertoli,et al.  AN ANTIBODY THAT INHIBITS IN VITRO BONE MARROW PROLIFERATION IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND APLASTIC ANEMIA , 1989, Arthritis and rheumatism.

[14]  R. Panush,et al.  'Rhupus' syndrome. , 1988, Archives of internal medicine.

[15]  J. Webb,et al.  Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. , 1987, Annals of the rheumatic diseases.